Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
Organ-on-a-chip academic research is in its blossom. Drug toxicity evaluation is a promising area in which organ-on-a-chip technology can apply. A unique advantage of organ-on-a-chip is the ability to integrate drug metabolism and drug toxic processes in a single device, which facilitates evaluation of toxicity of drug metabolites. Human organ-on-a-chip has been fabricated and used to assess drug toxicity with data correlation with the clinical trial. In this review, we introduced the microfluidic chip models of liver, kidney, heart, nerve, and other organs and multiple organs, highlighting the application of these models in drug toxicity detection. Some biomarkers of toxic injury that have been used in organ chip platforms or have potential for use on organ chip platforms are summarized. Finally, we discussed the goals and future directions for drug toxicity evaluation based on organ-on-a-chip technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 A liver chip system for drug toxicity testing. (A) Specific cell type (human, dog, rat) four-cell culture chip used for drug toxicity test [66]; (B) Perfusion-incubator-liver-chip (PIC) using CO2 gas pressure to drive the perfusion medium, which can be used for chronic toxicity repeated dose drug toxicity tests [67] (C) Liver chip combined with fluorescent probe to track mitochondrial function status in real time to monitor cell viability and metabolic function [68]; (D) Liver chip microdevice with a vascular layer, which is helpful for predicting the mechanism of drug liver toxicity at the microcirculation level [69].](https://figures.cochat.ai/paper-figures/dab1891c2b4447f58d4d5cc748a08042/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-1.jpg)
![Figure 2 A kidney chip system for drug toxicity testing. (A) Design of the human kidney proximal tubule-on-a-chip [77]. (B) Microfluidic device designs for single channel and multi-channel devices, and the final device assembly with notable features marked [81]. (C) Design for the device contains the glomerulus, Bowman’s capsule, proximal renal lumen, and capillary tubules [86].](https://figures.cochat.ai/paper-figures/c3c8407e79f44c1cae50f1fc8fd9a69c/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-2.jpg)
![Figure 3 A heart chip system for drug toxicity testing. (A) Schematic of the first microfluidic devices to CMs anisotropy [91]. (B) Representative tissues in the Biowire II platform [96]. (C) Design of the microfluidic device used for integrated heart/cancer-on-a-chip (iHCC) [98].](https://figures.cochat.ai/paper-figures/7595a99fc7424696b3930f8161f217c4/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-3.jpg)
![Figure 4 Schematic diagram of the research progress of neural chips. (A) The structure of the human brain organoid-on-a-chip to model prenatal nicotine exposure [112]. (B) Three-dimensional brain-on-a-chip with an interstitial level of flow and its application as an in vitro model of Alzheimer’s disease [114]. (C) A 3D microfluidic device to quantify orientational regeneration of injured neurons in AD by natural product concentration gradients [115].](https://figures.cochat.ai/paper-figures/65c715c882604f6c8a32d3946543047e/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-4.jpg)
![Figure 5 Some other-organ-on-a-chip systems for drug toxicity testing. (A) Schematic representation of the 3-lane OrganoPlate gut-on-a-chip model [122]. (B) A microengineered model of human pulmonary edema [127]. (C) Schematic drawing of the preparation of the in vitro blood–brain barrier (BBB) model [132].](https://figures.cochat.ai/paper-figures/40fc30dd7ccb419cb11c9b1436a0558f/drug-toxicity-evaluation-based-on-organ-on-a-chip-technology-a-review-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“To solve this problem, researchers developed multiorgan-on-a-chip systems to evaluate the efficacy and off-target toxicity of anticancer therapeutics.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“reconstructed critical functional alveolar-capillary interface in vitro, and they set two lateral micro-chambers into a microfluidic device to simulate pressure-driven stretching of the lungs during breathing [126].”
MethodBhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305 · cited 1×
“Also, it can regulate the oxygenation level, shear stress guarantees the barrier integrity of the cell layer, and it can control cell migration in vitro [5].”
BackgroundKim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
Organoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508 · cited 1×
“Through appropriate growth factor treatment, stem cell differentiation and self-organization into organ-specific cell types and tissues occurs, recreating the structure and function of organs in vitro [10].”
BackgroundCirculating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149 · cited 1×
“miRNA-122, miRNA-192 [26] Genomic markers √”
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice
Huh, D., Leslie, D. C., Matthews, B. D., Fraser, J. P., Jurek, S., Hamilton, G. A., Thorneloe, K. S., McAlexander, M. A., & Ingber, D. E. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004249 · Cited by 993 · cited 2×
“(B) A microengineered model of human pulmonary edema [127].”
BackgroundBiowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes
Nunes, S. S., Miklas, J. W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang, J., Massé, S., Gagliardi, M., Hsieh, A., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2524 · Cited by 952 · cited 1×
“When they contract, they pull the wires to produce a measurable deflection, which is transformed into a heartbeat signature [95].”
Background
Research works printed but not linked: 3
- Liu, 2011, Study on the changes of the electrical activity of neural networks by nanomaterials based on the microelectrode array neural chip, Tianjin Med. J., 39, 135
- Qu, 2018, Study on neurotoxicity model of SD rat neural stem cell evaluation drug, China Pharm. Aff., 32, 1079
- Zheng, X.N. (2010). Study on Cytotoxicity of Quantum Dots based on Cell Chip Platform. [Master’s Thesis, Fudan University].
Cited by
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Tumor-on-a-chip: from bioinspired design to biomedical application
Liu, X., Fang, J., Huang, S., Wu, X., Xie, X., Wang, J., Liu, F., Zhang, M., Peng, Z., & Hu, N. (2021) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00277-8 · Cited by 246
Microfluidic organ-on-a-chip models of human liver tissue
Moradi, E., Jalili-Firoozinezhad, S., & Solati-Hashjin, M. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.08.041 · Cited by 204
Navigating the complexities of drug development for inflammatory bowel disease
Honap, S., Jairath, V., Danese, S., & Peyrin‐Biroulet, L. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00953-0 · Cited by 138
“Banked PDOs permit future functional studies, such as toxicity and pharmacokinetic testing, and show considerable promise as future preclinical models in IBD 142–144 .”
Development of a Roadmap for Action on New Approach Methodologies in Risk Assessment
Escher, S. E., Partosch, F., Konzok, S., Jennings, P., Luijten, M., Kienhuis, A. S., de Leeuw, V. C., Reuss, R., Lindemann, K.-M., & Bennekou, S. H. (2022) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2022.en-7341 · Cited by 119
Rarokar, N., Yadav, S., Saoji, S., Bramhe, P., Agade, R., Gurav, S., Khedekar, P., Subramaniyan, V., Wong, L. S., & Kumarasamy, V. (2024) · International Journal of Pharmaceutics: X · doi:10.1016/j.ijpx.2024.100231 · Cited by 50
“Drug toxicity has been evaluated using a human organ-on-a-chip that has data correlated with a clinical trial (Cong et al., 2020).”
Stem Cells for Next Level Toxicity Testing in the 21st Century
Fritsche, E., Haarmann‐Stemmann, T., Kapr, J., Galanjuk, S., Hartmann, J., Mertens, P. R., Kämpfer, A. A. M., Schins, R. P. F., Tigges, J., & Koch, K. (2021) · Small · doi:10.1002/smll.202006252 · Cited by 75
Roadblocks confronting widespread dissemination and deployment of Organs on Chips
Alver, C. G., Drabbe, E., Ishahak, M., & Agarwal, A. (2024) · Nature Communications · doi:10.1038/s41467-024-48864-3 · Cited by 74
“…in series and parallel with each other can mimic the natural progression of a drug through different body compartments and provide more information on the potential systemic toxicity of a drug, aiding in the exclusion of toxic drugs at an earlier stage in the drug identi fi cation process 5,62 .”
Biosensors for detection of organophosphate pesticides: Current technologies and future directives
Kumaran, A., Vashishth, R., Singh, S., Surendran, U. P., James, A., & Chellam, P. V. (2022) · Microchemical Journal · doi:10.1016/j.microc.2022.107420 · Cited by 81
Emerging Technologies for In Vitro Inhalation Toxicology
Singh, A. V., Romeo, A. A., Scott, K., Wagener, S., Leibrock, L., Laux, P., Luch, A., Kerkar, P., Balakrishnan, S., Dakua, S. P., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100633 · Cited by 81
Shroff, T., Aina, K., Maass, C., Cipriano, M., Lambrecht, J., Tacke, F., Mosig, A., & Loskill, P. (2022) · Open Biology · doi:10.1098/rsob.210333 · Cited by 68
“Indeed, the combination of physiological requirements and the use of translatable endpoints are essential for the application ofMOCs in biomedical research, drug development and chemical toxicity [104].”
BackgroundAdvances in TEER measurements of biological barriers in microphysiological systems
Nazari, H., Shrestha, J., Naei, V. Y., Bazaz, S. R., Sabbagh, M., Thiery, J. P., & Warkiani, M. E. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115355 · Cited by 73
Gut microbiota in health and disease: advances and future prospects
Zhang, Y., Wang, H., Sang, Y., Liu, M., Wáng, Q., Yang, H., & Li, X. (2024) · MedComm · doi:10.1002/mco2.70012 · Cited by 80
Sunildutt, N., Parihar, P., Salih, A. R. C., Lee, S. H., & Choi, K. H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1139229 · Cited by 71
Basement membrane properties and their recapitulation in organ-on-chip applications
Salimbeigi, G., Vrana, N. E., Ghaemmaghami, A. M., Huri, P. Y., & McGuinness, G. B. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100301 · Cited by 57
Development of Skin-On-A-Chip Platforms for Different Utilizations: Factors to Be Considered
Ponmozhi, J., Dhinakaran, S., Varga‐Medveczky, Z., Fónagy, K., Bors, L. A., Iván, K., & Erdő, F. (2021) · Micromachines · doi:10.3390/mi12030294 · Cited by 61
“Several biomarkers of toxicity were determined by organ‐on‐a‐chip technology [81].”
MethodAdvanced Drug Delivery Micro- and Nanosystems for Cardiovascular Diseases
Iravani, S., & Varma, R. S. (2022) · Molecules · doi:10.3390/molecules27185843 · Cited by 61
“Microfluidic heart-on-chip devices can recapitulate the functionality levels of cardiac tissue and the communication between cells and extracellular matrices, thus providing suitable platforms for measurement of cellular dynamics along with the computational modeling for clinical purposes [91,93].”
BackgroundDabaghi, M., Shahriari, S., Saraei, N., Da, K., Chandiramohan, A., Selvaganapathy, P. R., & Hirota, J. A. (2021) · Micromachines · doi:10.3390/mi12020132 · Cited by 60
Developing organs‐on‐chips for biomedical applications
Sun, L., Chen, H., Xu, D., Liu, R., & Zhao, Y. (2024) · Smart Medicine · doi:10.1002/smmd.20240009 · Cited by 54
Using chemical and biological data to predict drug toxicity
Liu, A., Seal, S., Yang, H., & Bender, A. (2023) · SLAS Discovery · doi:10.1016/j.slasd.2022.12.003 · Cited by 54
Liver microphysiological platforms for drug metabolism applications
Kulsharova, G., & Kurmangaliyeva, A. (2021) · Cell Proliferation · doi:10.1111/cpr.13099 · Cited by 52
Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery
Lu, Q., & Julia, T. C. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031203 · Cited by 52
“to emulate organ-organ crosstalk, for example, long-term co-culture of liver spheroids with human neuronal tissues [82], the culture system lacks organ-specific conditions and microenvironmental cues because on-chip environments are usually identical across all organs/organoids and therefore may compromise the functio…”
BackgroundPolymeric nanoparticles as therapeutic agents against coronavirus disease
Charelli, L. E., de Mattos, G. C., Sousa-Batista, A. J., Pinto, J. C., & Balbino, T. A. (2022) · Journal of Nanoparticle Research · doi:10.1007/s11051-022-05396-5 · Cited by 51
Importance of toxicity testing in drug discovery and research
Gupta, R., Polaka, S., Rajpoot, K., Tekade, M., Sharma, M. C., & Tekade, R. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98367-9.00016-0 · Cited by 44
Moreira, A., Müller, M., Costa, P. F., & Kohl, Y. (2021) · Advanced Biology · doi:10.1002/adbi.202101139 · Cited by 52
Challenges and shortcomings of antibacterial discovery projects
Theuretzbacher, U., Baraldi, E., Ciabuschi, F., & Callegari, S. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.11.027 · Cited by 38
Space Medicines for Space Health
Tran, Q. D., Tran, V., Toh, L. S., Williams, P. M., Tran, N. N., & Hessel, V. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00681 · Cited by 41
Recent advances in liver‐on‐chips: Design, fabrication, and applications
Qiu, L., Kong, B., Kong, T., & Wang, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220010 · Cited by 44
Boghdeh, N. A., Risner, K. H., Barrera, M. D., Britt, C. M., Schaffer, D. K., Alem, F., Brown, J. A., Wikswo, J. P., & Narayanan, A. (2022) · Viruses · doi:10.3390/v14122799 · Cited by 39
A high-throughput gut-on-chip platform to study the epithelial responses to enterotoxins
Morelli, M., Rodríguez, M. C., & Queiroz, K. C. S. (2024) · Scientific Reports · doi:10.1038/s41598-024-56520-5 · Cited by 43
“Similarly, perfused liver and kidney organ-on-a-chip models also show enhanced drug sensitivity compared to static models 45 .”
Stem cells based in vitro models: trends and prospects in biomaterials cytotoxicity studies
Ahmed, U., Ahmed, R., Masoud, M. S., Tariq, M., Ashfaq, U. A., Augustine, R., & Hasan, A. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe6d8 · Cited by 34
“Organ-on-a-chip technology incorporates certain factors to replicate main characteristics within a microfabricated system with unique tissue microenvironments and architectures, enabling the development of 3D models that display native tissue functional hallmarks [94].”
InfluentialOrgan-on-Chip platforms to study tumor evolution and chemosensitivity
Dsouza, V. L., Kuthethur, R., Kabekkodu, S. P., & Chakrabarty, S. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188717 · Cited by 39
Sadeghzade, S., Hooshiar, M. H., Akbari, H., Tajer, M. H. M., Sahneh, K. K., Ziaei, S. Y., Jalali, F., & Akouchakian, E. (2024) · Applied Materials Today · doi:10.1016/j.apmt.2024.102231 · Cited by 40
Yang, Q., Wijerathne, H., Langston, J. C., Kiani, M. F., & Kilpatrick, L. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157770 · Cited by 31
Customizable Microfluidic Origami Liver‐on‐a‐Chip (oLOC)
Xie, X., Maharjan, S., Kelly, C. M., Liu, T., Lang, R. J., Alperin, R. C., Sebastian, S., Bonilla, D., Gandolfo, S., Boukataya, Y., et al. (2021) · Advanced Materials Technologies · doi:10.1002/admt.202100677 · Cited by 31
Self-citationAdvancing predictive toxicology: overcoming hurdles and shaping the future
Masarone, S., Beckwith, K. V., Wilkinson, M. R., Tuli, S., Lane, A., Windsor, S., Lane, J. S., & Hosseini-Gerami, L. (2025) · Digital Discovery · doi:10.1039/d4dd00257a · Cited by 31
“17 This technology also enables real-time analysis of cellular responses which is important as toxicity responses are o en time dependent.”
Environmental Toxicology Assays Using Organ-on-Chip
Akarapipad, P., Kaarj, K., Liang, Y., & Yoon, J. (2021) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-091620-091335 · Cited by 29
Simulation and modeling of physiological processes of vital organs in organ-on-a-chip biosystem
Seidi, S., Eftekhari, A., Khusro, A., Heris, R. S., Sahibzada, M. U. K., & Gajdács, M. (2021) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2021.101710 · Cited by 30
Singla, N., Gupta, G., Kulshrestha, R., Sharma, K., Bhat, A. A., Mishra, R., Patel, N. K., Thapa, R., Ali, H., Mishra, A., et al. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100460 · Cited by 31
Chowdhury, R., Bhuia, M. S., Hasan, M. S. A., Snigdha, H. M. S. H., Afrin, S., Büsselberg, D., Habtemariam, S., Gürer, E. S., Sharifi‐Rad, J., Aldahish, A. A., et al. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4318 · Cited by 29
“The assessment of drug toxicity can be conducted by several methodologies, including in silico analysis (Wu et al., 2020), in vivo experimentation on animal models (Ruggeri et al., 2014), and in vitro investigations utilizing organ- on- a-chip technology (Cong et al., 2020).”
Application Progress of Organoids in Colorectal Cancer
Luo, L., Ma, Y., Zheng, Y., Su, J., & Huang, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.815067 · Cited by 35
Organ‐On‐A‐Chip Devices: Technology Progress and Challenges
Obeid, P. J., Yammine, P., El‐Nakat, H., Kassab, R., Tannous, T., Nasr, Z., Maarawi, T., Dahdah, N., Safadi, A. E., Mansour, A., et al. (2024) · ChemBioChem · doi:10.1002/cbic.202400580 · Cited by 39
Tailoring biomaterials for biomimetic organs-on-chips
Sun, L., Bian, F., Xu, D., Luo, Y., Wang, Y., & Zhao, Y. (2023) · Materials Horizons · doi:10.1039/d3mh00755c · Cited by 27
Self-citationA generic pump‐free organ‐on‐a‐chip platform for assessment of intestinal drug absorption
Guo, Y., Xie, Y., & Qin, J. (2024) · Biotechnology Journal · doi:10.1002/biot.202300390 · Cited by 23
Organoid, organ-on-a-chip and traditional Chinese medicine
Yang, J., Jiang, Y., Li, M., Wu, K., Wei, S., Zhao, Y., Shen, J., Du, F., Chen, Y., Deng, S., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01071-8 · Cited by 23
“Currently, the liver, kidney, heart, nerve, intestines, lungs, blood-brain barrier, and some multi-organ chips (liver and kidney) have been used for drug toxicity evaluation [114].”
The Convergence of Artificial Intelligence and Microfluidics in Drug Research and Development
Qiao, D., Li, H., Zhang, X., Chen, X., Jiang, Z., Zou, J., Zhao, D., Zhu, W., Qian, X. H., & Li, H. (2025) · Engineering · doi:10.1016/j.eng.2025.07.025 · Cited by 25
Self-citationFunctional Evaluation and Nephrotoxicity Assessment of Human Renal Proximal Tubule Cells on a Chip
Jing, B., Yan, L., Li, J., Luo, P., Ai, X., & Tu, P. (2022) · Biosensors · doi:10.3390/bios12090718 · Cited by 21
“Discussion Worldwide, researchers are pushing the boundaries of nephrotoxicity prediction forward by improving the screening methodology, particularly with in vitro cell models, to minimize unnecessary risks in clinical settings and reduce the costs of pharmaceutical R&D [13,23].”
BackgroundInfluentialEmerging tissue engineering strategies for the corneal regeneration
Tafti, M. F., Aghamollaei, H., Moghaddam, M. M., Jadidi, K., ALIO, J. L., & Faghihi, S. (2022) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3309 · Cited by 24
“…and experimental applications such as drug delivery, drug screening, disease modeling, and chemical toxicity testing by genetic features of individual and/or specific pattern of each patient tissue (Cong et al., 2020; Gillaspie et al., 2016; Jiménez et al., 2019; Yang et al., 2020).”
BackgroundLynch, M. J., & Gobbo, O. L. (2021) · Nanomaterials · doi:10.3390/nano11102632 · Cited by 20
Sakolish, C., Moyer, H. L., Tsai, H.-H. D., Ford, L. C., Dickey, A. N., Wright, F. A., Han, G., Bajaj, P., Baltazar, M. T., Carmichael, P. L., et al. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad080 · Cited by 21
A Microfluidic Organ-On-A-Chip: Into the Next Decade of Bone Tissue Engineering Applied in Dentistry
Syahruddin, M. H., Anggraeni, R., & Ana, I. D. (2023) · Future Science OA · doi:10.2144/fsoa-2023-0061 · Cited by 20
Perry, A., Hadad, N., Chatterjee, E., Ramos, M. J., Farber‐Eger, E. H., Roshani, R., Stolze, L. K., Betti, M. J., Zhao, S., Huang, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101871 · Cited by 23
Sub-wavelength acoustic stencil for tailored micropatterning
Kolesnik, K., Segeritz, P., Scott, D. J., Rajagopal, V., & Collins, D. J. (2023) · Lab on a Chip · doi:10.1039/d3lc00043e · Cited by 18
Figueiredo, I. D., Bartenlian, B., van der Rest, G., Pallandre, A., & Halgand, F. (2023) · Proteomes · doi:10.3390/proteomes11020019 · Cited by 19
“Some good works are reviewed elsewhere [93].”
Comprehensive review of the traditional uses and the potential benefits of epimedium folium
Cui, J., Lin, L., Hao, F., Shi, Z., Gao, Y., Yang, T., Yang, C., Wu, X., Rong, G., Ru, Y., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1415265 · Cited by 20
“Women with POF typically exhibit ovarian infertility and low fertility (Cong et al., 2020).”
BackgroundSelf-citationБожков, А. И., Сідоров, В., Alboqai, O. K., Akzhyhitov, R. A., Kurguzova, N. I., Malyshev, A. B., Begai, M. A. Y. A., & Gromovoy, T. Y. (2021) · Translational Medicine of Aging · doi:10.1016/j.tma.2021.11.001 · Cited by 18
Otumala, A. E., Hellen, D. J., Luna, C. A., Delgado, P., Dissanayaka, A., Ugwumadu, C., Oshinowo, O. T., Islam, M. M., Shen, L., Karpen, S. J., et al. (2023) · Lab on a Chip · doi:10.1039/d2lc00940d · Cited by 17
Advancement of organ-on-chip towards next generation medical technology
Singh, G., Mishra, A., Mathur, A. K., Shastri, S., Nizam, A., Rizwan, A., Dadial, A. S., Firdous, A., & Hassan, H. (2024) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2024.100480 · Cited by 22
Didier, C. M., Orrico, J. F., Torres, O. S. C., Castro, J. M., Baksh, A., & Rajaraman, S. (2023) · Microsystems & Nanoengineering · doi:10.1038/s41378-023-00488-1 · Cited by 17
Çam, S. B., Dede, E. Ç., Gürbüz, N., Altun, B., & Korkusuz, P. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03674-8 · Cited by 14
Shrimali, S., Li, D., Knox, B., Tong, W., & Ning, B. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100187 · Cited by 15
Dabaghi, M., Tiessen, N., Cao, Q., Chandiramohan, A., Saraei, N., Kim, Y., Gupta, T., Selvaganapathy, P. R., & Hirota, J. A. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01200 · Cited by 13
Nephroscreen: A robust and versatile renal tubule-on-a-chip platform for nephrotoxicity assessment
Vriend, J., Vormann, M. K., Lanz, H. L., Joore, J., Trietsch, S. J., Rüssel, F. G. M., Jacobsen, B., Roth, A. B., Lu, S., Polli, J. W., et al. (2021) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2021.03.001 · Cited by 13
Organ‐on‐a‐Chip Technology and Global Multi‐Omics: Current Applications and Future Directions
Cao, X., Xia, C., Li, C., Deng, S., Cao, J., Yang, H., Wang, S., & Chen, P. (2026) · MedComm · doi:10.1002/mco2.70603 · Cited by 14
“However, after achieving the interconnection of 4–7 organ modules, maintaining long-term stability in whole-body-level simulations remains a major challenge for the future [ 181, 182 ].”
Jurowski, K., Niżnik, Ł., Frydrych, A., Kobylarz, D., Noga, M., Krośniak, A., Fijałkowska, O., Świdniak, A., & Ahuja, V. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111404 · Cited by 12
Direct Production of a Hyperpolarized Metabolite on a Microfluidic Chip
Barker, S. J., Dagys, L., Hale, W. G., Ripka, B., Eills, J., Sharma, M., Levitt, M. H., & Utz, M. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c05030 · Cited by 13
Unleashing the potential of cell painting assays for compound activities and hazards prediction
Odje, F., Meijer, D., von Coburg, E., van der Hooft, J. J. J., Dunst, S., Medema, M. H., & Volkamer, A. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1401036 · Cited by 11
From organ to system: multiorgan-on-a-chip platforms as next-generation biomedical simulators
Chen, C., Zhou, L., Kou, N., Li, X., Mao, H., & Liu, H. (2025) · Biofabrication · doi:10.1088/1758-5090/ae0dba · Cited by 11
“This leads to unpredictable toxicity to the liver, heart, kidney, and nervous system in clinical trials for many drugs deemed safe in preclinical studies [152], which significantly increases the cost and time of drug development while reducing research efficiency.”
Current Research Trends in the Application of In Vitro Three-Dimensional Models of Liver Cells
Yun, C., Kim, S. H., & Jung, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010054 · Cited by 15
“A unique advantage of a microchip/organ-ona-chip is that it can integrate the metabolic and toxic processes of drugs into a single device, making it more convenient to use when evaluating the toxicity of drug metabolites [40].”
InfluentialZhou, Z., Luo, D., Li, M., Lao, G., Zhou, Z., Dinnyés, A., Xu, W., & Sun, Q. (2023) · Toxins · doi:10.3390/toxins15050312 · Cited by 11
Choi, M. A., Rose, S., & Langouët, S. (2025) · Toxicology · doi:10.1016/j.tox.2025.154167 · Cited by 16
Effects of microenvironmental factors on assessing nanoparticle toxicity
Seo, S., Lee, J. E., Lee, K., & Kim, H. N. (2022) · Environmental Science Nano · doi:10.1039/d1en00925g · Cited by 10
Hendriks, H. R. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189467 · Cited by 11
Li, Z., Li, J., Sun, M., Men, L., Wang, E., Zhao, Y., Li, K., & Gong, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1046722 · Cited by 9
“The traditional two-dimensional culture in vitro can moderately replace the animal model, but it cannot replicate the physiological environment of cells in vivo (Cong et al., 2020).”
BackgroundKim, H., Kim, E.-J., Ngo, H. V., Nguyen, H. D., Park, C., Choi, K. H., Park, J.-B., & Lee, B. (2023) · Pharmaceuticals · doi:10.3390/ph16091330 · Cited by 10
Gholizadeh, H., Cheng, S., Kourmatzis, A., Xing, H., Traini, D., Young, P. M., & Ong, H. X. (2022) · Bioengineering · doi:10.3390/bioengineering9040150 · Cited by 11
“[6,7] • Drug toxicity studies performed on organ-on-chips with improved physiological relevance”
BackgroundEmerging Paradigms in Bioengineering the Lungs
Mohgan, R., Candasamy, M., Mayuren, J., Singh, S. K., Gupta, G., Dua, K., & Chellappan, D. K. (2022) · Bioengineering · doi:10.3390/bioengineering9050195 · Cited by 9
“Several drugs were reported to be screened using this technique [80].”
Efficient Parahydrogen-Induced 13 C Hyperpolarization on a Microfluidic Device
Barker, S. J., Dagys, L., Levitt, M. H., & Utz, M. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c03271 · Cited by 8
“In this way, cellular processes and functions as well as their response to external stimuli such as drugs, 4 therapeutic targets, 5 − 7 toxins, 8,9 and oxygen or nutrient supply 10,11 can be studied systematically.”
BackgroundMicrotoxicology by microfluidic instrumentation: a review
Cao, J., Chande, C., & Köhler, J. M. (2022) · Lab on a Chip · doi:10.1039/d2lc00268j · Cited by 9
Bodas, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95533-1.00011-4 · Cited by 12
Bonaccorsi, S. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837673476-00461 · Cited by 10
Costa, S. D. F. Z., Carneiro, A. B., Lebre, F., Meneses, J., Ainla, A., Moura, C., Alfaro‐Moreno, E., & Ribeiro, A. R. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502518 · Cited by 7
Toxicological Analysis of Hepatocytes Using FLIM Technique: In Vitro versus Ex Vivo Models
Rodimova, S. A., Elagin, V. V., Karabut, M. M., Koryakina, I., Timin, A. S., Загайнов, В. Е., Zyuzin, M. V., Вадимовна, З. Е., & Kuznetsova, D. S. (2021) · Cells · doi:10.3390/cells10112894 · Cited by 6
“Thus, microfluidics has emerged as a suitable tool for cell manipulation and cell study, as the culture of cells in such flow conditions facilitates the supply of nutrients or other compounds (drugs, toxins) required to study the cellular response [30].”
MethodRecent technological advances in lab-on-a-chip for bone remodeling
Kim, S., Rajendran, A. K., Amirthalingam, S., Kim, J. H., So, K., & Hwang, N. S.-Y. (2023) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2023.100360 · Cited by 11
Amend, N., Koller, M., Schmitt, C., & Worek, F. (2024) · Toxicology Letters · doi:10.1016/j.toxlet.2024.01.013 · Cited by 6
A public-private partnership for the express development of antiviral leads: a perspective view
Mayburd, A. L. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1811676 · Cited by 6
Gupta, R., Radhakrishnan, R. A., Kabekkodu, S. P., & Chakrabarty, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189504 · Cited by 6
Microengineering the Liver: Strategies for Constructing Functional Liver‐on‐a‐Chip Devices
Wang, J., Liang, Z., Wang, J., Li, Z., Wang, S., Wei, Y., Xie, X., & Huang, D. (2026) · Exploration · doi:10.1002/exp2.70137 · Cited by 6
Ameliorating Effect of Vitamin E on Liver Damage Caused by Administering Tartrazine in Male Mice
Al-Shaikh, T. M. (2021) · Asian Journal of Pharmaceutical Research and Health Care · doi:10.18311/ajprhc/2021/26407 · Cited by 5
Experimental Models for Studying Structural and Functional State of the Pathological Liver (Review)
Krylov, D. P., Rodimova, S. A., Karabut, M. M., & Kuznetsova, D. S. (2023) · Современные технологии в медицине · doi:10.17691/stm2023.15.4.06 · Cited by 6
Dutta, D., Ray, A., Bhattacharya, E., Ghosh, B., & Bahadur, M. (2024) · Toxicology International · doi:10.18311/ti/2024/v31i1/35473 · Cited by 4
Organs on chips: fundamentals, bioengineering and applications
Awad, N. K. (2024) · Journal of Artificial Organs · doi:10.1007/s10047-024-01460-0 · Cited by 4
“Recent research [131, 132] and reviews [104, 133–136] have discussed humans on chips models and their possible applications.”
Organ-On-A-Chip (OOAC) Technology: Impact on Drug Screening and Personalized Medicine
Singh, S., Das, N., Rathore, M., Nishad, A., Kumari, N., & Guha, R. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00409-w · Cited by 8
“Creating constructions with micro-scale resolution allows for exact manipulation of specific cells inside platforms [66].”
Gao, T., Lin, T., Gao, C., Luo, L., Cui, L., Lv, J., Guo, L., Tang, W., Hu, J., Fan, Y., et al. (2025) · The Innovation Medicine · doi:10.59717/j.xinn-med.2025.100136 · Cited by 4
Digestive Tract and Salivary Glands
McKnight, C. A., Diehl, L. J., & Bergin, I. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-821046-8.00001-3 · Cited by 6
Organ-on-a-Chip and Lab-on-a-Chip Technologies in Cardiac Tissue Engineering
Marazzi, D., Trovalusci, F., Nardo, P. D., & Carotenuto, F. (2025) · Biomimetics · doi:10.3390/biomimetics11010018 · Cited by 4
“Experiments conducted on a heart-kidney system have shown functional communication between cardiac and renal tissues in flow, opening new perspectives to describe systemic effects [123].”
Cox, M. C., Mendes, R. G. P. R., Halwachs, K. N., Domenici, G., Brito, C., & Boghaert, E. R. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2216016 · Cited by 3
Multiorgan-on-a-chip: Design and Applications
Khan, H., Khan, S. A., & Parvez, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00009-7 · Cited by 3
Qin, W., Yang, Z., Yin, J., Chen, D., Huo, J., Wang, J., Wang, L., & Zhuo, Q. (2022) · Nutrients · doi:10.3390/nu14214615 · Cited by 3
“Specifically, microfluidic organ chips can immediately adjust the microenvironment associated with cell growth and function in accordance with cell type, while the flowing medium can supply adequate nutrients and exclude harmful metabolic wastes from the periphery of the cells [7].”
BackgroundElnour, A. A. M., Ashammakhi, N. A., & Sallam, E. B. (2025) · Springer eBooks · doi:10.1007/978-981-97-8518-6_7 · Cited by 3
Metadata
- Authors
- Cong, Y., Han, X., Wang, Y., Chen, Z., Lu, Y., Liu, T., Wu, Z., Jin, Y., Luo, Y., & Zhang, X.
- Affiliations
- Dalian University of Technology (CN)
- Soochow University (CN)
- Shenzhen University (CN)
- Dalian Institute of Chemical Physics (CN)
- Dalian Medical University (CN)
- Health Science Center, Shenzhen University, Shenzhen 518060, China
- Corresponding author
- Luo, Yong
- Zhang, Xiuli
- Venue
- Micromachines
- Publisher
- MDPI AG
- Published
- 2020-04-03
- Volume
- 11
- Issue
- 4
- Pages
- 381
- ISSN
- 2072-666X (ISSN-L)
- PMC
- PMC7230535
- OpenAlex
- W3014092941
- Cited by
- 140
- References
- 146
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 34 · 2023: 23 · 2022: 21 · 2021: 20 · 2020: 5
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Micromachines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (21675017)
- National Key Research and Development Program of China (2017YFC1702001)
- Shenzhen Fundamental Research and Discipline Layout project (JCYJ2018050815247476)
- China Postdoctoral Science Foundation (21675017)
- Sanming Project of Medicine in Shenzhen (SZSM201612049)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- organ-on-a-chip, microfluidic organ models, drug metabolism, multi-organ-on-a-chip, in vitro toxicity testing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.